Full GMP-Compliant Validation of Bone Marrow-Derived Human CD133 (+) Cells as Advanced Therapy Medicinal Product for Refractory Ischemic Cardiomyopathy.

According to the European Medicine Agency (EMA) regulatory frameworks, Advanced Therapy Medicinal Products (ATMP) represent a new category of drugs in which the active ingredient consists of cells, genes, or tissues. ATMP-CD133 has been widely investigated in controlled clinical trials for cardiovas...

Full description

Bibliographic Details

Published in:	BioMed Research International Vol. 2015; pp. 1 - 11
Main Authors:	Belotti, Daniela, Gaipa, Giuseppe, Bassetti, Beatrice, Cabiati, Benedetta, Spaltro, Gabriella, Biagi, Ettore, Parma, Matteo, Biondi, Andrea, Cavallotti, Laura, Gambini, Elisa, Pompilio, Giulio
Format:	research tables/charts Journal Article
Published:	Wiley-Blackwell 10/1/2015
Online Access:	View this record in EBSCOhost